← Back to Search

Quantifying the Venous Congestion Curve of a Tissue Oximetry Device

N/A
Waitlist Available
Led By Ramon Llull, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hour 0.5
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the effects of blood pressure cuff on tissue oxygenation in the arm & hand. A cuff is inflated, monitored every 2 min, then deflated.

Eligible Conditions
  • Skin Flap Necrosis
  • Postoperative Complications

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hour 0.5
This trial's timeline: 3 weeks for screening, Varies for treatment, and hour 0.5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Transcutaneous Oximetry (StO2) of Vascular Occlusion Test at 0.5 Hours

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ViOptix T.OxExperimental Treatment1 Intervention
ViOptix T.Ox machine is used to measure the oxygenation of composite tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ViOptix
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,297 Total Patients Enrolled
Ramon Llull, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Tissue Oximetry Clinical Trial Eligibility Overview. Trial Name: NCT05592145 — N/A
Skin Flap Necrosis Research Study Groups: ViOptix T.Ox
Skin Flap Necrosis Clinical Trial 2023: Tissue Oximetry Highlights & Side Effects. Trial Name: NCT05592145 — N/A
Tissue Oximetry 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592145 — N/A
~12 spots leftby Dec 2025